Key points are not available for this paper at this time.
Sumatriptan, a 5HT1 receptor agonist administered by the subcutaneous route, causes a vasopressor response in the systemic and pulmonary arterial circulations and coronary artery vasoconstriction.
MacIntyre et al. (Mon,) studied this question.